# $ONEKEY Social Sentiment & Intelligence — 2026-10-03 16:20 UTC

> **Asset:** $ONEKEY  
> **Momentum Status:** Sudden Spike  
> **Timestamp:** 2026-10-03 16:20 UTC (2026-10-03T16:20:00Z)  
> **Canonical URL:** https://cryptitalk.com/2026-10-03-16-20/crypto/ONEKEY  
> **Overview Brief:** https://cryptitalk.com/2026-10-03-16-20/crypto.md  

---

## 10-Minute Social Metrics
- **Posts Analyzed:** 1
- **Total Impressions:** 361
- **Likes:** 5
- **Retweets:** 0
- **Comments:** 3

---


## Momentum & Sentiment Analysis
Total Engagement - Comments: 3, Retweets: 0, Likes: 5, Impressions: 361


---

## Cited Community Posts & Evidence


### Post #1 by @BioTechTraderSD
> **Author:** [@BioTechTraderSD](https://x.com/BioTechTraderSD)  
> **Metrics:** 1 likes · 0 retweets · 0 comments · 220 views  


> **Source Link:** [https://x.com/BioTechTraderSD/status/2106395190726640038](https://x.com/BioTechTraderSD/status/2106395190726640038)  


> **Visual Context:** A presentation slide titled "SCY-770: Well-Characterized, Phase 2 - Ready AMPK Activator" highlights clinical trial data, with yellow emphasis on pre-clinical efficacy in a NAFLD Phase 2a study and a safety profile involving 273 individuals.  

> 
> "Here's why the upcoming P1 
$SCYX
 SCY-770 pk/pd at higher doses matters"




---


## Contributing Accounts

- `@kuk47377341` (https://x.com/kuk47377341)